🇺🇸 Intrathecal Methotrexate in United States

11 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Pulmonary Embolism — 2 reports (18.18%)
  2. Anal Ulcer — 1 report (9.09%)
  3. Anorectal Discomfort — 1 report (9.09%)
  4. Clostridium Test Positive — 1 report (9.09%)
  5. Diarrhoea — 1 report (9.09%)
  6. Drug Toxicity — 1 report (9.09%)
  7. Dyspnoea — 1 report (9.09%)
  8. Febrile Neutropenia — 1 report (9.09%)
  9. Fungal Infection — 1 report (9.09%)
  10. Generalised Tonic-Clonic Seizure — 1 report (9.09%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is Intrathecal Methotrexate approved in United States?

Intrathecal Methotrexate does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Intrathecal Methotrexate in United States?

Sun Yat-sen University is the originator. The local marketing authorisation holder may differ — check the official source linked above.